Skip to main content
NCBI home page
Transactions of the American Clinical and Climatological Association logoLink to Transactions of the American Clinical and Climatological Association
. 1987;98:128–134.

Familial Mediterranean fever--an update.

S E Goldfinger
PMCID: PMC2279719  PMID: 3303616

Full text

PDF
128

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aisen P. S., Haines K. A., Given W., Abramson S. B., Pras M., Serhan C., Hamberg M., Samuelsson B., Weissmann G. Circulating hydroxy fatty acids in familial Mediterranean fever. Proc Natl Acad Sci U S A. 1985 Feb;82(4):1232–1236. doi: 10.1073/pnas.82.4.1232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bar-Eli M., Ehrenfeld M., Levy M., Gallily R., Eliakim M. Leukocyte chemotaxis in recurrent polyserositis (familial Mediterranean fever). Am J Med Sci. 1981 Jan-Feb;281(1):15–18. doi: 10.1097/00000441-198101000-00002. [DOI] [PubMed] [Google Scholar]
  3. Benson M. D., Kleiner E. Synthesis and secretion of serum amyloid protein A (SAA) by hepatocytes in mice treated with casein. J Immunol. 1980 Feb;124(2):495–499. [PubMed] [Google Scholar]
  4. De Beer F. C., Mallya R. K., Fagan E. A., Lanham J. G., Hughes G. R., Pepys M. B. Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet. 1982 Jul 31;2(8292):231–234. doi: 10.1016/s0140-6736(82)90321-x. [DOI] [PubMed] [Google Scholar]
  5. Dinarello C. A. Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med. 1984 Nov 29;311(22):1413–1418. doi: 10.1056/NEJM198411293112205. [DOI] [PubMed] [Google Scholar]
  6. Ehrenfeld M., Levy M., Sharon P., Rachmilewitz D., Eliakim M. Gastrointestinal effects of long-term colchicine therapy in patients with recurrent polyserositis (familial mediterranean fever). Dig Dis Sci. 1982 Aug;27(8):723–727. doi: 10.1007/BF01393768. [DOI] [PubMed] [Google Scholar]
  7. Goldfinger S. E. Colchicine for familial Mediterranean fever. N Engl J Med. 1972 Dec 21;287(25):1302–1302. doi: 10.1056/NEJM197212212872514. [DOI] [PubMed] [Google Scholar]
  8. Goldfinger S. E. Familial Mediterranean fever--a progress report. West J Med. 1977 Jul;127(1):40–41. [PMC free article] [PubMed] [Google Scholar]
  9. Ilfeld D., Kuperman O. Correction of a suppressor cell deficiency in four patients with familial Mediterranean fever by in vitro or in vivo colchicine. Clin Exp Immunol. 1982 Oct;50(1):99–106. [PMC free article] [PubMed] [Google Scholar]
  10. Levin M., Franklin E. C., Frangione B., Pras M. The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. J Clin Invest. 1972 Oct;51(10):2773–2776. doi: 10.1172/JCI107098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Matzner Y., Brzezinski A. C5a-inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever. N Engl J Med. 1984 Aug 2;311(5):287–290. doi: 10.1056/NEJM198408023110503. [DOI] [PubMed] [Google Scholar]
  12. Maury C. P., Teppo A. M. Mechanism of reduced amyloid-A-degrading activity in serum of patients with secondary amyloidosis. Lancet. 1982 Jul 31;2(8292):234–237. doi: 10.1016/s0140-6736(82)90322-1. [DOI] [PubMed] [Google Scholar]
  13. Zemer D., Pras M., Sohar E., Modan M., Cabili S., Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med. 1986 Apr 17;314(16):1001–1005. doi: 10.1056/NEJM198604173141601. [DOI] [PubMed] [Google Scholar]
  14. van der Meer J. W., Vossen J. M., Radl J., van Nieuwkoop J. A., Meyer C. J., Lobatto S., van Furth R. Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet. 1984 May 19;1(8386):1087–1090. doi: 10.1016/s0140-6736(84)92505-4. [DOI] [PubMed] [Google Scholar]

Articles from Transactions of the American Clinical and Climatological Association are provided here courtesy of American Clinical and Climatological Association

RESOURCES